Clinical Trials
9
Active:3
Completed:5
Trial Phases
2 Phases
Phase 1:4
Phase 2:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (55.6%)Phase 1
4 (44.4%)Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- DS Biopharma
- Target Recruit Count
- 219
- Registration Number
- NCT03817190
- Locations
- 🇺🇸
DS Investigational Site 524, Birmingham, Alabama, United States
🇺🇸DS Investigational Site 528, Huntington Beach, California, United States
🇺🇸DS Investigational Site 502, Los Angeles, California, United States
Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- DS Biopharma
- Target Recruit Count
- 5
- Registration Number
- NCT03676933
- Locations
- 🇮🇪
DS Biopharma Investigational Site, Dublin, Ireland
Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- DS Biopharma
- Target Recruit Count
- 42
- Registration Number
- NCT03676036
- Locations
- 🇩🇪
DS Biopharma Investigational Site, Lubeck, Germany
Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- DS Biopharma
- Target Recruit Count
- 327
- Registration Number
- NCT02925793
- Locations
- 🇿🇦
DS Biopharma Site, Cape Town, South Africa
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- DS Biopharma
- Target Recruit Count
- 321
- Registration Number
- NCT02864498
- Locations
- 🇿🇦
DS Biopharma Site, Cape Town, South Africa
- Prev
- 1
- 2
- Next
News
No news found